Chinese english Germany Japanese Korea

Glaucoside C

Glaucoside C Struktur
81474-89-7
CAS-Nr.
81474-89-7
Englisch Name:
Glaucoside C
Synonyma:
Glaucoside C;6H-2,3,5-Trioxapentaleno[1',6':5,6,7]cyclonona[1,2-a]naphthalen-6-one, 10-[(O-2,6-dideoxy-3-O-methyl-α-L-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-L-ribo-hexopyranosyl)oxy]-2a,4,4a,6a,7,9,10,11,12,12a,12b,13,14,14b-tetradecahydro-11-hydroxy-2a,12a-d...
CBNumber:
CB53260839
Summenformel:
C41H62O15
Molgewicht:
794.93
MOL-Datei:
81474-89-7.mol
Request For Quotation

Glaucoside C Eigenschaften

Siedepunkt:
908.9±65.0 °C(Predicted)
Dichte
1.33±0.1 g/cm3(Predicted)
pka
13.50±0.70(Predicted)

Sicherheit

Glaucoside C Chemische Eigenschaften,Einsatz,Produktion Methoden

Glaucoside C Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Glaucoside C Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 		+1-781-999-5354
support@targetmol.com United States 19973 58
Wuhan ChemFaces Biochemical Co., Ltd. 18607101326 15172504745
 aileen@chemfaces.com China 7059 55
Chengdu Push Bio-Technology Co., Ltd. 028-85370565-229 18080489829
 3004654993@qq.com China 9220 60
Nanjing Digger Medical Technology Co. Ltd. 025-025-51191215 18013836722
 2399235533@qq.com China 4933 58
cjbscvictory 13348960310 13348960310
 3003867561@qq.com China 10011 58
Chengdu Push Bio-Technology Co., Ltd. 18080489829
 3004654993@qq.com China 9209 58
Shanghai Moqi Biological Technology Co., LTD 021-38218169 13341702378
 190129269@qq.com China 9117 58
  • Glaucoside C
  • 6H-2,3,5-Trioxapentaleno[1',6':5,6,7]cyclonona[1,2-a]naphthalen-6-one, 10-[(O-2,6-dideoxy-3-O-methyl-α-L-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-3-O-methyl-β-L-ribo-hexopyranosyl)oxy]-2a,4,4a,6a,7,9,10,11,12,12a,12b,13,14,14b-tetradecahydro-11-hydroxy-2a,12a-d...
  • 81474-89-7
Copyright 2019 © ChemicalBook. All rights reserved